Colsubsidio’s Oncological Clinic Leads in Prostate Cancer Care
Colsubsidio Clinic Recognized for Prostate Cancer Risk management
Table of Contents
- Colsubsidio Clinic Recognized for Prostate Cancer Risk management
- Colsubsidio Clinic: Leading teh Way in Prostate Cancer Care
- What is the Colsubsidio Oncological Health Clinic recognized for?
- What is the “2025 Ranking of Good Practices”?
- What specific recognition did the clinic receive?
- How does this recognition benefit patients?
- Is prostate cancer a major health concern?
- What are the statistics for prostate cancer treatment at Colsubsidio in 2024?
- How does early detection impact prostate cancer outcomes?
- When did the Colsubsidio Oncological Clinic begin providing care?
- How many patients has the clinic served since its opening?
- What is the clinic’s approach to patient care?
- What types of cancers does the clinic focus on?
- How many oncology consultations were conducted in 2024?
- How many individuals are currently undergoing active cancer treatment?
- What other types of cancers are treated at Colsubsidio?
- What is the Health Colsubsidio healthcare network like?
- How does this extensive network support cancer care?
- Summary of Key Statistics
BOGOTÁ, Colombia (AP) – The Colsubsidio Oncological Health Clinic has been recognized as a leading institution in cancer risk management, notably in prostate cancer care, according to the 2025 Ranking of Good Practices.
National Recognition for Cancer Care
The high-cost account (CAC) identified Colsubsidio as one of the top three health service providers (IPS) in Colombia for overall cancer risk management. The clinic secured the top spot nationally for its prostate cancer care protocols.
Commitment to Excellence
“This recognition is a testament to health Colsubsidio’s commitment and excellence,” said Carlos Urueña, deputy director of Health Colsubsidio. “It drives us to continue leading with innovation, empathy, and scientific rigor to face the challenges posed by cancer in Colombia.”
Prostate Cancer: A Leading Health Concern
Prostate cancer remains a significant health concern, identified by the CAC as a leading cause of cancer-related deaths among men. In 2024, the Colsubsidio Oncological Clinic treated 2,621 men for prostate cancer, with 72% of those cases being newly diagnosed.
Early Detection Key to Improved outcomes
The clinic’s emphasis on early detection has yielded positive results. In 2024, 90% of patients were classified according to the stage of their cancer, and 53% were diagnosed in the early stages.Early detection substantially improves treatment options and recovery prospects.
Thorough Cancer Care Since 2020
Since opening in 2020, the Colsubsidio Oncological Clinic has provided specialized care to more than 37,545 cancer patients. The clinic emphasizes a comprehensive and patient-centered approach.
Focus on High-Prevalence Cancers
In 2024, the clinic conducted 15,552 oncology consultations, focusing on prevalent cancers such as breast, prostate, colon, and rectal cancers. Currently, 11,540 individuals are undergoing active treatment for various cancers, including breast, skin, prostate, and thyroid cancers.
Extensive Healthcare Network
Health Colsubsidio operates a large healthcare network, including 1.7 million assigned users, seven clinics, 44 medical centers, and 501 drug stores. This extensive network reinforces its commitment to health, innovation, and clinical excellence in comprehensive cancer care.
Colsubsidio Clinic: Leading teh Way in Prostate Cancer Care
What is the Colsubsidio Oncological Health Clinic recognized for?
the Colsubsidio Oncological Health Clinic has been recognized as a leading institution in cancer risk management, especially in prostate cancer care, according to the 2025 Ranking of Good Practices.
What is the “2025 Ranking of Good Practices”?
The 2025 Ranking of Good Practices is an evaluation that assesses healthcare providers’ performance. The awards for this ranking is presented by the “high-cost account” (CAC), which identified Colsubsidio as one of the top three health service providers (IPS) in Colombia for overall cancer risk management.
What specific recognition did the clinic receive?
The Colsubsidio Oncological Health Clinic secured the top spot nationally in Colombia for its prostate cancer care protocols.
How does this recognition benefit patients?
This recognition highlights Colsubsidio’s commitment to excellence in cancer care. As stated by Carlos Urueña, deputy director of Health Colsubsidio, it motivates the clinic to continue leading through innovation, empathy, and scientific rigor in addressing cancer challenges in Colombia. Patients benefit from the clinic’s dedication to providing high-quality, patient-centered care, especially in the area of prostate cancer.
Is prostate cancer a major health concern?
Yes, prostate cancer remains a significant health concern. It is identified as a leading cause of cancer-related deaths among men.
What are the statistics for prostate cancer treatment at Colsubsidio in 2024?
In 2024, the Colsubsidio Oncological Clinic treated 2,621 men for prostate cancer.Of these cases, 72% were newly diagnosed.
How does early detection impact prostate cancer outcomes?
Early detection is key to improved outcomes. In 2024, the clinic’s emphasis on early detection led to positive results:
Classification: 90% of patients were classified according to the stage of their cancer.
Early Diagnosis: 53% of patients were diagnosed in the early stages.
Early diagnosis significantly improves treatment options and prospects for recovery.
When did the Colsubsidio Oncological Clinic begin providing care?
The clinic has been providing specialized cancer care since 2020.
How many patients has the clinic served since its opening?
The Colsubsidio Oncological Clinic has provided specialized care to more than 37,545 cancer patients since it opened in 2020.
What is the clinic’s approach to patient care?
The clinic emphasizes a comprehensive and patient-centered approach.
What types of cancers does the clinic focus on?
The clinic focuses on prevalent cancers, including prostate, breast, colon, and rectal cancers.
How many oncology consultations were conducted in 2024?
In 2024, the clinic conducted 15,552 oncology consultations.
How many individuals are currently undergoing active cancer treatment?
Currently,11,540 individuals are undergoing active treatment for various cancers.
What other types of cancers are treated at Colsubsidio?
Patients are receiving treatment for breast, skin, prostate, and thyroid cancers.
What is the Health Colsubsidio healthcare network like?
Health Colsubsidio operates an extensive healthcare network,comprising:
1. 7 million assigned users
2. Seven clinics
3. 44 medical centers
4. 501 drug stores
How does this extensive network support cancer care?
This extensive network reinforces Health Colsubsidio’s commitment to health, innovation, and clinical excellence in comprehensive cancer care.
Summary of Key Statistics
| Feature | Details |
| —————————– | ————————————————————————- |
| Recognition | Top-ranked in Colombia for prostate cancer care protocols. |
| Year of Recognition | 2025 |
| Prostate Cancer Patients (2024) | 2,621 men treated |
| Newly Diagnosed (2024) | 72% of prostate cancer cases |
| Early-Stage Diagnosis (2024) | 53% of patients diagnosed in early stages |
| Total Cancer patients Served | Over 37,545 as 2020 |
| Oncology Consultations (2024) | 15,552 |
| Patients in Active Treatment | 11,540 |